<DOC>
	<DOCNO>NCT00158795</DOCNO>
	<brief_summary>To assess safety reactogenicity GSK Biologicals ' Haemophilus influenza type b vaccine co-administered without Chinese DTPw vaccine administer alone healthy infant ( 3 , 4 5 month age )</brief_summary>
	<brief_title>Assess Safety &amp; Reactogenicity GSK Biologicals ' Hib Vaccine Co-administered With Without Chinese DTPw Vaccine</brief_title>
	<detailed_description>All subject randomize two group . One group receive DTPw vaccine co-administered Hib another group receive DTPw vaccine alone . A specific follow-up solicit local general symptom vaccination . A specific follow-up unsolicited symptom vaccination . Recording serious adverse event report study period .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>A male female infant , include , 11 17 week age time first vaccination . Planned administration vaccine foreseen study protocol period start 30 day administration first vaccine dose end 30 day last dose . Chronic administration immunosuppressant immunemodifying drug birth administration first dose study vaccine . Use investigational nonregistered product ( drug vaccine ) within 30 day precede first dose study vaccine , plan use study period .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>4 Months</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>